Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Egrifta
2. Tesamorelin
3. Th-9507
4. Th9507
1. 901758-09-6
2. Th9507
3. Unii-lgw5h38ve3
4. Tesamorelin Acetate [usan]
5. Lgw5h38ve3
6. (3e)-hex-3-enoylsomatoliberin (human) Acetate (salt)
1. Tesamorelin
2. Egrifta
| Molecular Weight | 5196 g/mol |
|---|---|
| Molecular Formula | C223H370N72O69S |
| Hydrogen Bond Donor Count | 84 |
| Hydrogen Bond Acceptor Count | 78 |
| Rotatable Bond Count | 187 |
| Exact Mass | 5194.7444797 g/mol |
| Monoisotopic Mass | 5192.7377700 g/mol |
| Topological Polar Surface Area | 2400 Ų |
| Heavy Atom Count | 365 |
| Formal Charge | 0 |
| Complexity | 12800 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 44 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Growth Substances
Signal molecules that are involved in the control of cell growth and differentiation. (See all compounds classified as Growth Substances.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tesamorelin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tesamorelin Acetate, including repackagers and relabelers. The FDA regulates Tesamorelin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tesamorelin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tesamorelin Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tesamorelin Acetate supplier is an individual or a company that provides Tesamorelin Acetate active pharmaceutical ingredient (API) or Tesamorelin Acetate finished formulations upon request. The Tesamorelin Acetate suppliers may include Tesamorelin Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Tesamorelin Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tesamorelin Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tesamorelin Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tesamorelin Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tesamorelin Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tesamorelin Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tesamorelin Acetate suppliers with NDC on PharmaCompass.
Tesamorelin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tesamorelin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tesamorelin Acetate GMP manufacturer or Tesamorelin Acetate GMP API supplier for your needs.
A Tesamorelin Acetate CoA (Certificate of Analysis) is a formal document that attests to Tesamorelin Acetate's compliance with Tesamorelin Acetate specifications and serves as a tool for batch-level quality control.
Tesamorelin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Tesamorelin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tesamorelin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tesamorelin Acetate EP), Tesamorelin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tesamorelin Acetate USP).
LOOKING FOR A SUPPLIER?
